Key result
Genetic studies reveal that fibromuscular dysplasia is associated with impaired prostacyclin signaling, fibrillar collagen defects, and genes involved in actin cytoskeleton and calcium homeostasis.
Why the study?
The causes of noninflammatory and nonatherosclerotic stenosis in fibromuscular dysplasia (FMD), which predominantly affects early middle-age women, are less understood than atherosclerotic stenosis.
Recent genetic studies suggest that fibromuscular dysplasia is driven by mechanisms involving impaired prostacyclin signaling, collagen defects, and altered vascular contraction.
No takes yet. Share an insight, caveat, or question.
Should not yet change FMD management; leaves open these pathways as hypothesis-generating targets for mechanistic and therapeutic studies.
Georges et al. (2022) conducted a review in Fibromuscular dysplasia (FMD). Genetic factors and molecular origins was evaluated. Genetic studies reveal that fibromuscular dysplasia is associated with impaired prostacyclin signaling, fibrillar collagen defects, and genes involved in actin cytoskeleton and calcium homeostasis.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: